Semyanov Pavel Sergeyevich

Semyanov Pavel Sergeyevich

Career

2019

In 2019, Pavel Semyanov said that he came to Groteks in May 2014 as financial director. Prior to that, he worked for five years as the general director of the "network company," where 300 people worked. According to SPARK-Interfax, Semyanov headed the Automobile Service Service CJSC in St. Petersburg.

2023: Appointment as CEO of Solopharm

On June 23, 2023, Pavel Semyanov was appointed the new general director of the St. Petersburg pharmaceutical company Solopharm (LLC Grotex""). He replaced Oleg Zherebtsov, who took over as chairman of the board of directors of Groteks LLC and head of Solopharm Group of Companies.

As explained to the publication "Pharmaceutical Bulletin," Zherebtsov continues to lead the enterprises of the group of companies, redistributing part of the operational issues between other heads of enterprises. The reason for this was the growth of the group of companies.

I see for myself a new horizon of opportunities related to the development of the company's operating strategy and concentration in key areas: the commissioning of new capacities, the development of the biotechnology segment, the construction of new production sites and the increase in the company's capitalization, "said Oleg Zherebtsov, who is the founder of Solopharm.

Before being appointed to the post of general director, Pavel Semyanov worked as financial director of Solopharm. The company produces a wide range of drugs for cardiology, pulmonology, neurology, rheumatology, gastroenterology and other areas. According to the SPARK-Interfax system, by the end of June 2023, Groteks LLC belongs to Nelovia LTD, a company registered in Cyprus. The company has five production sites in the city with a total area of ​ ​ more than 36,000 square meters. m. The manufacturer's portfolio of drugs includes 210 marketing authorizations. The company exports its products to 14 countries.^[1]

Notes